000			01732na a2200217 4500
999			_c6725 _d6725
003			PC6725
005			20191107141827.0
008			130622s2013 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aOgando Portilla, Nadia _92599 _ePsiquiatría
245	0	0	_aAntidepressant induced recurrent hyponatremia: A case report. _h[caso clínico]
260			_bActas Españolas De Psiquiatría, _c2013
300			_a41(6):361-4.
500			_aFormato Vancouver: Martínez-Cortés M, Ogando-Portilla N, Pecino-Esquerdo B, Pérez-Maciá V. Antidepressant induced recurrent hyponatremia: A case report. Actas Esp Psiquiatr. 2013 Nov-Dec;41(6):361-4.
501			_aPMID: 24203508
504			_aContiene 15 referencias
520			_aHyponatremia is a known adverse effect of antidepressants. A review of the literature was performed in relation to one case treated in our hospital to identify risk factors and possible psychopharmacologic alternatives. A 57-year old woman with HIV and HCV suffered 4 episodes of severe hyponatremia within 5 months of treatment involving the following drugs: thiazide diuretic, venlafaxine, citalopram, olanzapine, haloperidol, enalapril and escitalopram. Risk of hyponatremia is higher in patients treated with antidepressants, especially selective seroton in reuptake inhibitors. Advance age, female gender, thiazidic diuretics, sodium levels in the lower limits and low weight increase the risk. All the SSRIs can produce hyponatremia. In most of the cases, this effect appears in the first month. It is not dose dependent and the patient recovers when treatment is interrupted. Early detection as well as the evaluation of concomitant riskfactors in all patients starting antidepressant are important. It seems necessary to control ions periodically and to choose safe drugs.
710			_9150 _aServicio de Psiquiatría
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/6/pc6725.pdf _ySolicitar documento
942			_n0 _2ddc _cCAS